ALEXANDRIA, Va., Aug. 5 -- United States Patent no. 12,698,281, issued on Aug. 4.
"Thiazole derivatives for therapeutic use" was invented by Josep Bassaganya-Riera (Blacksburg, Va.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are thiazole derivative compounds that can reduce CD4+ IFNGamma+ T cells and inhibit or reduce inflammation. Also provided are methods of treating diseases characterized by gastrointestinal tract inflammation using the compounds."
The patent was filed on Aug. 21, 2023, under Application No. 18/235,949.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearc...